Daejeon, South Korea

Ji-Na You

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Abl Bio Inc., Legochem Biosciences, Inc.. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 30.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ji-Na You: Innovator in Antibody-Drug Conjugates

Introduction

Ji-Na You is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of antibody-drug conjugates (ADCs). His innovative work focuses on targeting specific proteins associated with various diseases, including cancer.

Latest Patents

Ji-Na You holds a patent for an "Antibody-drug conjugate comprising antibody against human ROR1 and use for the same." This invention relates to new ADCs that target ROR1, which is over-expressed in certain cancers. The patent outlines methods for preparing these ADCs and their applications in treating and preventing illnesses associated with ROR1 over-expression. The pharmaceutical composition described in the patent includes an antibody that binds to ROR1 or an antigen-binding fragment thereof.

Career Highlights

Throughout his career, Ji-Na You has worked with notable companies in the biotechnology sector. He has been associated with Legochem Biosciences, Inc. and Abl Bio Inc., where he has contributed to advancing research and development in therapeutic solutions.

Collaborations

Ji-Na You has collaborated with esteemed colleagues, including Yun-Hee Park and Ho Young Song. Their combined expertise has furthered the progress of innovative projects in the field of antibody-drug conjugates.

Conclusion

Ji-Na You's work in developing antibody-drug conjugates represents a significant advancement in targeted cancer therapies. His innovative approach and dedication to research continue to impact the biotechnology industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…